Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000671009 | SCV000795944 | pathogenic | Hurler syndrome | 2017-11-29 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000671009 | SCV001520419 | pathogenic | Hurler syndrome | 2020-01-23 | criteria provided, single submitter | clinical testing | This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. |
Labcorp Genetics |
RCV003591770 | SCV004292282 | pathogenic | Mucopolysaccharidosis type 1 | 2023-07-06 | criteria provided, single submitter | clinical testing | This premature translational stop signal has been observed in individual(s) with mucopolysaccharidosis type I (PMID: 24798265). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 555230). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Trp402*) in the IDUA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in IDUA are known to be pathogenic (PMID: 11735025, 21480867). |